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INTRODUCTION
Necrobiosis lipoidica (NL), first described by 
Oppenheim1 in 1929, is a rare chronic idiopathic granu-
lomatous disease of collagen degeneration with a risk of 
ulceration,2 which appears predominantly in lower extrem-
ities. This disease is associated with diabetes and affects 
about 0.3%–1.2% of patients with diabetes.3 However, 
there is no evidence that uncontrolled glycemia can be 
correlated with NL manifestations.4 The average onset age 
is 30 years, and women are mainly affected.5 NL’s lesions 
typically exhibit 1–3 well-circumscribed asymptomatic 
papules, slowly aggregating into plaques. These lesions 
seem violaceous, with a central area that can become 
yellow-brown discolored. This area is often covered by an 
atrophic, waxy, and eroded skin. The degeneration of the 
epidermic collagen leads to the development of telangiec-
tasias. Seventy-five percentage of NL lesions are painless, 
but the remaining 25% can be painful,6 especially if ulcer-
ated. Up to 35% of patients suffering from NL develop 
ulcerations after minor traumatic events.7 Although NL 
is a benign condition, an occasional finding of squamous 
carcinoma has been reported; in this case, a proper follow-
up is recommended.8 We present the case of a patient suf-
fering from NL on the medial surface of the left leg.
CASE REPORT
A 30-year-old woman model presented with a 14-year 
history of progressive expanding lesion of the medial sur-
face of the left leg (Fig. 1). On examination, we reported a 
25 cm × 12 cm lesion covered by yellow-colored, atrophic, 
and scaly skin, surrounded by a red border with a light 
edge and smooth surface. A lamellar hyperkeratosis with 
thickening of the skin was also observed. A dilation of the 
venous and capillary reticulum, both in the dermis and 
in the subcutaneous layer, was present. The lesion was 
painless, and sensitivity was normal. The patient had an 
18-year history of type 1 diabetes treated with insulin and 
a 5-year history of celiac disease. A skin biopsy showed col-
lagen degeneration in the deep dermis, with peripheral 
infiltration of lymphocytes and histiocytes. Infiltration of 
lymphocytes and granulocytes was present in the superfi-
cial dermis, supporting the diagnosis of NL. After careful 
evaluation of the patient’s expectations, and discussion 
with her on the technical treatment options, including 
skin expansion and free vascularized tissue transfer, the 
patient received a staged resection of the lesion associated 
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to bilayered dermal matrix (Integra Dermal Regeneration 
Template; LifeScience Corporation; Princeton, N.J.) and 
skin grafts. Skin grafts were applied after full template 
revascularization, which occurred from 14 to 20 days after 
placement (Fig. 2). As donor sites, we chose the bilateral 
groin and the inferior abdomen to obtain hidden scars. 
During the harvesting of the abdominal graft, nodular 
subcutaneous lesions were found, which were not palpa-
ble at preoperatory workout. Histologic examination clas-
sified them as amyloidosis. After the healing of the wound, 
the patient underwent 10 sessions of carbon dioxide laser 
in association with Dye laser to minimize the visibility of 
the scars. At 2-year follow-up, the skin grafts appeared 
stable and the patient was very satisfied with the aesthetic 
result (Figs. 3–5).
DISCUSSION
NL is a rare disease, and there are no sufficient cases 
to perform prospective clinical trials. This is the reason 
why most of the literature findings are case reports and 
small-scale clinical trials.9 There are few comparative stud-
ies evaluating different treatments of NL, and it is impos-
sible to draw up a guideline for therapy. The condition 
may seldom heal on its own (up to 17% cases).10
Peckruhn et al11 delivered a critical assessment of 
reports on the treatment of NL published up to year 2000. 
In their work, it can be seen that with an increased number 
of treated patients, the percentage of successful cases actu-
ally decreases. The common practice of starting treatment 
with topical therapy can be recommended. Other thera-
peutic options, such as surgical resection and skin grafts, 
should be considered as well.11 In our case, the patient did 
not respond to medical treatment. The response’s failure to 
Fig. 1. Preoperative view of a large nL lesion involving the left leg.
Fig. 2. Intraoperative view showing skin grafting after partial resec-
tion of the lesion. skin grafts were harvested from the groin region 
during this surgical step.
Fig. 3. Final outcome at 2-year follow-up.
Fig. 4. Histologic view of the resected lesion (×40) demonstrating 
extended nL involving the dermal layer. Histiocytes are present as 
well as multinucleated giant cells.
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the medical therapy negatively affected the psychologic life 
and self-esteem of the patient. Depression and other mood 
disorders are in fact often associated with this dermatologic 
condition.12 The surgical approach to this type of lesions is 
less studied than the medical one in the literature.
The relationship between glycemic control and NL in 
patients with diabetes mellitus was investigated by Mistry et 
al.13 In this recent literature review, 622 studies were identi-
fied but only 10 met the inclusion criteria (8 case reports and 
2 case series). Of the 24 patients with NL, only 13 reported 
resolution of the lesions after implementing various meth-
ods of glycemic control (diet, insulin regimen, and pancre-
atic transplantation). The authors conclude that glycemic 
control may have a role in influencing the prognosis of NL, 
but still there is insufficient evidence to support this claim.
As far as the specific context of our patient is con-
cerned, a radical 1-stage resection of the lesion would have 
left a too wide a defect to be covered by a single full-thick-
ness skin graft, without tissue prefabrication techniques. 
As microsurgeons, an alternative option that we have 
thoughtfully considered for the treatment of this case was 
the use of free flaps. Free flaps are largely qualified for 
managing any kind of leg defects. The size of the lesion, 
however, reduced the options of coverage with respect to 
the choice of an appropriate free fasciocutaneous flap. 
Only the anterolateral thigh flap could perhaps meet all 
the theoretical requirements, including high aesthetic 
expectations of patients, at the expense of a long scar 
into her thigh. Van Landuyt et al14 reported the versatil-
ity of the deep inferior epigastric artery (DIEP) flap for 
the reconstruction of inferior limbs, and this technique is 
shown to be capable of covering large skin defects.15 The 
DIEP flap appeared to us as a reliable option, but because 
of the location of perforators, the abdominal scar could 
not be placed low enough to be hidden. In addition, we 
had some concerns regarding the thickness of the flap to 
restore a quite thin defect over the tibia.
At a deeper reflection, the indication for surgery was 
merely aesthetic. The young patient was psychologically dis-
tressed, and complained not being able of wearing skirts 
or bathing suits, with consequent significant professional 
implications. Additionally, the free flap technique is not 
devoid of risks, mostly in a patient with diabetes. Assi et al16 
demonstrated that diabetes itself is not a risk factor for the 
outcome of a free flap, but we must consider that this proce-
dure may entail the sacrifice of one leg’s artery in a patient 
with a considerable risk of developing a diabetic foot.17
Staged surgical resection and coverage with skin grafts 
allowed us to achieve full excision of NL. Skin grafts were 
harvested from the groin region bilaterally. As a last pro-
cedure, an aesthetic mini-abdominoplasty was performed, 
and the resected skin used as the graft to cover the resid-
ual defect. By this, we were able to achieve full coverage of 
the leg without determining visible donor site scars.18
After meticulous postoperatory follow-up and com-
plete graft take, the patient was scheduled for laser treat-
ment to further improve aesthetics.19,20 At 2-year follow-up, 
the patient was very happy with the results and was back to 
her profession, as no recurrence of the lesion occurred.
During the last procedure, we found multiple subcuta-
neous nodules compatible with nodular amyloidosis due 
to injection of insulin. It is uncommon, like in our patient, 
that the deposit of amyloid was unpalpable.21 It was not 
necessary to change the insulin therapy because this con-
dition is supposed to be related to its concentration, and 
not to the type used. Amyloidosis due to injection of insu-
lin is not correlated to systemic amyloidosis, and it can be 
avoided by the rotation of the injection site.22,23
CONCLUSIONS
NL is a rare condition related to diabetes. Topical treat-
ment with corticosteroids is usually the first step, and it is 
possible to see a complete regression in the majority of the 
patient response. However, there is no consistent guide-
line for the treatment. It is necessary to engage further 
studies to standardize the medical and surgical approach.
In our opinion, the conservative surgical procedure 
we chose yielded excellent aesthetic results in a high-
demanding patient. In conclusion, our experience dem-
onstrates that dermal templates and seriates full-thickness 
skin grafts harvested from hidden donor sites deserve 
to be carefully considered in the treatment of NL not 
responding to medical therapy.
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Fig. 5. two-year postoperative view of the patient (wearing under-
wear) showing hidden abdominoplasty and groin scars.
PRS Global Open • 2020
4
REFERENCES
 1. Oppenheim M. Necrobiosis lipoidica diabeticorum. Med J Aust. 
1934;1:258–258. 
 2. Sibbald C, Reid S, Alavi A. Necrobiosis lipoidica. Dermatol Clin. 
2015;33:343–360. 
 3. Özkur E. Atypical presentation of necrobiosis lipoidica in a pedi-
atric patient. Pediatr Dermatol. 2018;36:e31–e33. 
 4. Mistry BD, Alavi A, Ali S, et al. A systematic review of the rela-
tionship between glycemic control and necrobiosis lipoidica 
diabeticorum in patients with diabetes mellitus. Int J Dermatol. 
2017;56:1319–1327. 
 5. Lause M, Kamboj A, Fernandez Faith E. Dermatologic manifesta-
tions of endocrine disorders. Transl Pediatr. 2017;6:300–312. 
 6. Reid SD, Ladizinski B, Lee K, et al. Update on necrobiosis 
lipoidica: a review of etiology, diagnosis, and treatment options. 
J Am Acad Dermatol. 2013;69:783–791. 
 7. Muller SA, Winkelmann RK. Necrobiosis lipoidica diabetico-
rum. A clinical and pathological investigation of 171 cases. Arch 
Dermatol. 1966;93:272–281. 
 8. Lefkovits Y, Adler A. Fatal squamous cell carcinoma from nec-
robiosis lipoidica diabeticorum in a diabetic patient. Endocrinol 
Diabetes Metab Case Rep. 2019;2019:19-0007. 
 9. Feily A, Mehraban S. Treatment modalities of necrobio-
sis lipoidica: a concise systematic review. Dermatol Reports. 
2015;7:5749. 
 10. British Association of Dermatologists. Necrobiosis Lipoidica. 
Patient information leaflet. 2019.
 11. Peckruhn M, Tittelbach J, Elsner P. Update: therapie der necro-
biosis lipoidica. J Dtsch Dermatol Ges. 2017;15:151–158. 
 12. Jagmag T, Tirant M, Lotti T. Link between cutaneous infec-
tion, stress and depression. J Biol Regul Homeost Agents. 
2017;31:1037–1041.
 13. Mistry BD, Alavi A, Ali S, et al. Asystematic review of the rela-
tionship between glycemic control and necrobiosis lipoidica 
diabeticorum in patients with diabetes mellitus. Intern J Dermatol. 
2017;56:1319–1327. 
 14. Van Landuyt K, Blondeel P, Hamdi M, et al. The versatile DIEP 
flap: its use in lower extremity reconstruction. Br J Plast Surg. 
2005;58:2–13. 
 15. Qing LM, Tang JY. Use of intraflap and extraflap microvascular 
anastomoses in combination for facilitating bipedicled DIEP/
SIEA free flap for reconstruction of circumference soft tissue 
defect of extremity. Microsurgery. 2019;39:190–191. 
 16. Assi C, Samaha C, Chamoun Moussa M, et al. A comparative 
study of the reverse sural fascio-cutaneous flap outcomes in the 
management of foot and ankle soft tissue defects in diabetic and 
trauma patients. Foot Ankle Spec. 2019;12:432–438. 
 17. Schreml S, Berneburg M. The global burden of diabetic wounds. 
Br J Dermatol. 2017;176:845–846. 
 18. Osman OF, Emara S. Extended use of full-thickness skin grafts, 
employing variable donor sites. World J Plast Surg. 2018;7:159–165.
 19. Ohshiro T, Ohshiro T, Sasaki K. Laser scar management tech-
nique. Laser Ther. 2013;22:255–260. 
 20. Baccarani A, Follmar KE, Erdmann D, et al. Face transplanta-
tion surgical options and open problems in cadaveric models: a 
review article. Microsurgery. 2013;33:239–246. 
 21. Nagase T, Keiichi I, Yoshiya K, et al. Insulin-derived amyloidosis 
without a palpable mass at the insulin injection site: a report of 
two cases. J Diabetes Investig. 2019. [Epub ahead of print]. 
 22. Wiley J, Bernárdez C, María A. Nodular amyloidosis at the sites of 
insulin injections. J Cutan Pathol. 2015;42:496–502. 
 23. Adani R, Delcroix L, Tarallo L, et al. Reconstruction of post-
traumatic bone defects of the humerus with vascularized fibular 
graft. J Shoulder Elbow Surg. 2008;17:578–584. 
